House blasts NCI mammography policy

Article

Pressure is mounting on theNational Cancer Institute to retract its controversial guidelineson mammography screening of women in their 40s. The House of RepresentativesCommittee on Government Operations last month issued a seethingreport criticizing the

Pressure is mounting on theNational Cancer Institute to retract its controversial guidelineson mammography screening of women in their 40s. The House of RepresentativesCommittee on Government Operations last month issued a seethingreport criticizing the NCI's policy change (SCAN 10/26/94). Thereport charges that flawed, biased decision-making by NCI officialsled to the institute's elimination of its mammography screeningrecommendations for women aged 40 to 49.

Controversy has raged since last December when the agency brokeconsensus with 12 medical and cancer organizations, eliminatingguidelines that promoted biennial screening for younger women(SCAN 12/15/93). The change stemmed from the NCI's InternationalWorkshop, where a panel reviewed data from eight randomized clinicaltrials and assessed the effectiveness of breast cancer screeningin various age groups. It concluded that younger women did notshow a statistically significant decrease in mortality after 10to 12 years' follow-up.

The House committee report, entitled "Misused Science: TheNational Cancer Institute's Elimination of Mammography Guidelinesfor Women in their Forties," faulted the agency for appointingworkshop leaders who were known critics of mammography screeningof younger women. The report also criticized the NCI for excludingmedical, scientific and public health groups, whose consensusformed the backbone of the NCI's prior policy. By not includingpositive data on the screening of younger women, the report asserts,the NCI "failed to uphold standards and scientific integrity.The result tarnished the scientific integrity of NCI and wastedmany taxpayer dollars.

In conclusion, the committee urged the NCI to revise its mammographyscreening statement to provide a more balanced view of the scientificevidence, and to hold a new consensus conference on the issue.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.